PHAR 株価推移チャート
PHAR 財務
Pharming Group N.V.
$12.8
-0.58%
$-0.07
終値： Jun 12, 16:00:00 GMT-4
$12.5
-2.38%
$-0.3
アフターマーケット：Jun 12, 19:59:17 GMT-4
戻る
Pharming Group N.V. (PHAR) 財務
主要データ
前終値
$12.88
始値
$12.7
当日レンジ
$12.5 - $12.98
52週レンジ
$9.53 - $21.34
取引高
6.6K
平均取引高
16.1K
配当利回り
--
1株当たり利益(TTM)
0.19
時価総額
$882.8M
Pharming Group N.V.とは何ですか？
Pharming Group NV is a holding company, which engages in the development of pharmaceutical products for the treatment of rare diseases and unmet medical needs. The company employs 407 full-time employees The firm is engaged in the development, production and commercialization of human therapeutic proteins to be used in the therapies. The firm's product portfolio is aimed at treatments for genetic disorders, blood-related disorders, infectious and inflammatory diseases, tissue and bone damage and surgical/traumatic bleeding. Its core product, RUCONEST (conestat alfa) is a recombinant human C1 esterase inhibitor approved for the treatment of acute Hereditary Angioedema (HAE) attacks in patients in Europe, the Unites States, Israel and South Korea. The product is available on a named-patient basis in other territories where it has not yet obtained marketing authorization.
